When taking all gliomas into account, patients who had higher FGFR3 expression in their tumors showed much improved survival than those had lower FGFR3 expression, both in CGGA and TCGA dataset (Log-rank test, Figure 5A–5C). The gene discussed is FGFR3; the disease is glioma.